Business
CSL (ASX:CSL) share price wobbles on COVID vaccine news – The Motley Fool Australia
The CSL Limited (ASX: CSL) share price is on watch after the UK found “possible links” between the AstraZeneca vaccine and blood clots.
The CSL Limited (ASX: CSL) share price is a little wobbly this morning after negative vaccine news overnight from the United Kingdom.
The pharmaceutical giant, which produces and supplies the AstraZeneca PLC (LSE: AZ)COVID-19 vaccine in Australia, is trading close to its opening price after news that the UK medical regulator has found a “possible link” between the vaccine and blood clotting in younger adults. The regulator noted that blood clotting was considered a rare side-effect of the vaccine.
…
-
Noosa News23 hours agoThe story behind the historic Highgate Hill Queenslander destroyed by Brisbane storm
-
General20 hours agoThousands of US flights delayed as shutdown bites
-
General19 hours agoRBA governor Bullock says a severe market downturn would raise financial stability concerns
-
Noosa News22 hours agoWhy Cam Green staying at No.3 could help get the best out of Steve Smith during the 2025/26 Ashes